Zum Inhalt

Bender MedSystems

Bender MedSystems GmbH

Wien
Wien
ÖSTERREICH
Partnerkategorie unternehmerisch tätig

Projektbeteiligungen

Als Partner

SerologyTest

abgeschlossen 2020
Simplex and Multiplex Serology Test based on SARS-CoV2 antigenic peptides pre-selected through peptide library screening
The goal of the project is the development of highly specific Anti-SARS-CoV-2 ELISA technology-based simplex and Luminex® technology-based multiplex serologic immunoassays based on pre-selected SARS-CoV-2 specific antigenic peptides. Such peptide candidates were initially identified through bioinformatics…